COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: In this group, in addition to the current treatment of Covid-19, which is remdesivir and methylprednisolone or dexamethasone, nebulizing ethanol is also added in th
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 69 Years
Inclusion criteria
Inclusion criteria: Positive RT-PCR test of SARS-COV2 Less than 7 days of starting of signs or symptoms of COVID-19 Age 15-69 yr
Exclusion criteria
Exclusion criteria: Pregnancy History of Asthma History of Alcohol dependency History of Seizure Contraindication of Ethanol addministration Disagreement of patient physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Requires non-temporary hospitalization. Timepoint: Daily until 5 daus. Method of measurement: Counting the days.;Needing to ICU admission. Timepoint: Days 7, 14, 21. Method of measurement: Evaluate medical file records.;Mortality Rate. Timepoint: Days 7, 14, 21, 28. Method of measurement: Evaluate medical file records.;Respiratory status of patients. Timepoint: ?Days from 1 to 5. Method of measurement: SPO2.;Inflammatory condition. Timepoint: Days 1-5-14. Method of measurement: WBC counting -CRP titration.;Clinical status. Timepoint: Days 1-5-14. Method of measurement: Score from the table of clinical signs. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Moazam
Esfahan University of Medical Sciences
Outcome results
None listed